---
title: "Zenas Biopharma (ZBIO.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ZBIO.US/norm.md"
symbol: "ZBIO.US"
name: "Zenas Biopharma"
parent: "https://longbridge.com/zh-CN/quote/ZBIO.US.md"
datetime: "2026-05-21T07:29:18.582Z"
locales:
  - [en](https://longbridge.com/en/quote/ZBIO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZBIO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZBIO.US/norm.md)
---

# Zenas Biopharma (ZBIO.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.46 | -4.54 | -1.22 | -1.25 | -0.8032 |
| ROE | -112.10% | -438.59% | -94.48% | -79.74% | -45.01% |
| 营业收入 | - | 0.0000 | - | - | 10.00M |
| 净利润 | -80.99M | -240.44M | -51.50M | -52.22M | -33.57M |
| 营业利润 | -77.35M | -71.31M | -47.58M | -55.16M | -37.33M |
| 毛利率 | - | - | - | - | -249.15% |
| 净利率 | - | - | - | - | -335.73% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 747.68M | 383.64M | 322.02M | 293.08M | 333.77M |
| 权益乘数 | 2.23 | 1.58 | 1.64 | 1.22 | 1.17 |
| 每股净资产 | 5.38 | 4.44 | 4.65 | 5.69 | 6.80 |
| 资产周转率 | 0.0000 | 0.0265 | 0.0414 | 0.0608 | 0.0784 |
| 现金及短投 | 717.21M | 343.19M | 290.88M | 273.28M | 312.38M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 1.12M | 1.39M | 857000.00 | 1.07M | 1.28M |
| 净债务 | -450.38M | -341.87M | -290.09M | -272.27M | -311.15M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -75.20M | -52.41M | -41.13M | -41.74M | -37.05M |
| 投资现金流 | 31.61M | -93.36M | 40.04M | -112.29M | -86.27M |
| 融资现金流 | 433.48M | 140.84M | 72.62M | 1.72M | 99000.00 |
| 自由现金流 | -45.53M | -59.47M | -28.47M | -24.09M | -26.49M |
| 现金流充裕率 | -3759800.00% | - | - | - | -205838.89% |
| 举债与偿债 | 267.50M | - | - | - | - |
| 资本支出 | -2000.00 | 0.0000 | 0.0000 | 0.0000 | -18000.00 |